+36.1%
MRNA vs SPXS
-79.6%
+115.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SPXS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -2.4% | +7.8% | +4.2% |
| 7D | -1.1% | +2.5% | -3.6% | +0.2% |
| 30D | +126.1% | +4.2% | +121.9% | +132.3% |
| 3M | +190.0% | -9.3% | +199.3% | +181.4% |
| 6M | +157.2% | -30.7% | +187.9% | +125.5% |
| YTD | +388.2% | -28.1% | +416.3% | +339.0% |
| 1Y | +467.0% | -35.1% | +502.1% | +393.4% |
| 3Y | +36.1% | -79.6% | +115.7% | -16.7% |
| All | +36.1% | -79.6% | +115.7% | -16.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXS.
Daily Out/Under-Performance
Portfolio return minus SPXS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SPXS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling